JP2024509376A5 - - Google Patents
Info
- Publication number
- JP2024509376A5 JP2024509376A5 JP2023549551A JP2023549551A JP2024509376A5 JP 2024509376 A5 JP2024509376 A5 JP 2024509376A5 JP 2023549551 A JP2023549551 A JP 2023549551A JP 2023549551 A JP2023549551 A JP 2023549551A JP 2024509376 A5 JP2024509376 A5 JP 2024509376A5
- Authority
- JP
- Japan
- Prior art keywords
- cyclodextrin
- cholesterol
- days
- derivative
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163150908P | 2021-02-18 | 2021-02-18 | |
| US63/150,908 | 2021-02-18 | ||
| PCT/US2022/017090 WO2022178318A1 (en) | 2021-02-18 | 2022-02-18 | Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024509376A JP2024509376A (ja) | 2024-03-01 |
| JP2024509376A5 true JP2024509376A5 (https=) | 2025-02-27 |
Family
ID=82800248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023549551A Pending JP2024509376A (ja) | 2021-02-18 | 2022-02-18 | 家族性ヘテロ接合型及びホモ接合型高コレステロール血症のシクロデキストリンによる治療方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20220260597A1 (https=) |
| EP (1) | EP4294403A4 (https=) |
| JP (1) | JP2024509376A (https=) |
| AU (1) | AU2022222756A1 (https=) |
| WO (1) | WO2022178318A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024053812A1 (en) * | 2022-09-08 | 2024-03-14 | Renatus Inc. | Methods for the treatment of chronic kidney disease |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6773719B2 (en) * | 1994-03-04 | 2004-08-10 | Esperion Luv Development, Inc. | Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias |
| AU773385B2 (en) * | 1999-05-14 | 2004-05-27 | Esperion Luv Development, Inc. | Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto |
| WO2001055301A2 (en) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
| CA2553710A1 (en) * | 2004-01-15 | 2005-07-28 | Aska Pharmaceutical Co., Ltd. | Abca1 stabilizer |
| CA2737924A1 (en) * | 2008-10-06 | 2010-04-15 | Joshua Robert Schultz | Methods of treating inflammation |
| WO2011116245A2 (en) * | 2010-03-19 | 2011-09-22 | Carolus Therapeutics, Inc. | Methods of treating inflammation |
| US8372877B2 (en) * | 2010-04-16 | 2013-02-12 | Cumberland Pharmaceuticals | Stabilized statin formulations |
| MX371073B (es) * | 2012-04-13 | 2020-01-15 | L&F Res Llc | Método para utilizar ciclodextrina. |
| EP3405501B1 (en) * | 2016-01-21 | 2023-11-15 | Aten Porus Lifesciences | Cyclodextrin based polymers, methods, compositions and applications thereof |
| CN107854448A (zh) * | 2017-11-06 | 2018-03-30 | 广州市桐晖药业有限公司 | 一种烟酸片及其制备方法 |
| EP3870181B1 (en) * | 2018-10-26 | 2024-08-14 | Keros Therapeutics, Inc. | Crystal forms of an alk2 inhibitor |
| KR20230096975A (ko) * | 2020-08-27 | 2023-06-30 | 베렌 테라퓨틱스 피.비.씨. | 사이클로덱스트린을 이용한 콜레스테롤 결정 색전증 치료 방법 |
-
2022
- 2022-02-18 JP JP2023549551A patent/JP2024509376A/ja active Pending
- 2022-02-18 AU AU2022222756A patent/AU2022222756A1/en not_active Abandoned
- 2022-02-18 EP EP22757042.1A patent/EP4294403A4/en active Pending
- 2022-02-18 WO PCT/US2022/017090 patent/WO2022178318A1/en not_active Ceased
- 2022-02-18 US US17/675,170 patent/US20220260597A1/en not_active Abandoned
-
2023
- 2023-08-04 US US18/365,835 patent/US20230375576A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6491089B2 (ja) | シクロデキストリンを使用するための方法 | |
| JP2018203747A5 (https=) | ||
| JP5938394B2 (ja) | 安定化スタチン製剤 | |
| JP2012528796A5 (https=) | ||
| US20220000824A1 (en) | Treatment of pulmonary arterial hypertension using therapeutically effective oral doses of 10-nitro-9(e)-octadec-9-enoic acid | |
| KR20120046125A (ko) | 페길화된 유리카아제 치료 중에 혈청 요산을 모니터링하여 주입 반응의 위험성 및 반응의 항체?매개 상실을 예측하는 방법 및 키트 | |
| JP2017509624A5 (https=) | ||
| JP6632999B2 (ja) | 神経疾患および大脳損傷の処置のための組成物および方法 | |
| JP2024509376A5 (https=) | ||
| US20240209097A1 (en) | Treatment regimens | |
| Vuorio et al. | Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia | |
| US20230375576A1 (en) | Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins | |
| JP2021529766A5 (https=) | ||
| JP2024109841A (ja) | 冠動脈疾患における積極的脂質低下療法 | |
| JP2021501793A (ja) | 心疾患、心血管疾患及び関連する病状と症状を治療し保護する方法 | |
| Efthimiadis | Rosuvastatin and cardiovascular disease: did the strongest statin hold the initial promises? | |
| JP2022543084A (ja) | リポソーム及びその使用 | |
| Skoczyńska et al. | Postprandial lipemia in diabetic men during hypolipemic therapy | |
| Wilkinson et al. | * Real-World Experience with Inclisiran at a Large Academic Lipid Clinic | |
| US20240425838A1 (en) | TREATMENT OF ADVANCED IgA NEPHROPATHY | |
| Jonas Häner et al. | Evolocumab for Early Reduction of LDL-Cholesterol Levels in Patients with Acute Coronary Syndromes (EVOPACS) | |
| Cabezas et al. | Efficacy and safety of alirocumab in patients with established atherosclerotic vascular disease before the first cardiovascular event: Pooled analysis of phase 3 ODYSSEY studies | |
| CN101115480A (zh) | 马尼地平和他汀类药物的治疗组合 | |
| Zannas | Methylomic signatures mediate the effect of psychosocial stress on coronary heart disease | |
| Lovell et al. | SAT0489 PREVALENCE OF AUTOIMMUNE DISEASES IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS |